CLRB vs XOM · $20.8M cap vs P/E 24, rev $201.16B
Cellectar Biosciences Inc (CLRB) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Cellectar Biosciences Inc (CLRB) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
CLRB does not have a complete income-statement cache yet.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CLRB currently screens at market cap $20.8M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CLRB and XOM stock pages for the full models.
Not investment advice.